دورية أكاديمية
109O Phase I study of MEDI9253, a recombinant Newcastle Disease Virus encoding interleukin-12, in combination with durvalumab in participants with select advanced/metastatic solid tumors
| العنوان: | 109O Phase I study of MEDI9253, a recombinant Newcastle Disease Virus encoding interleukin-12, in combination with durvalumab in participants with select advanced/metastatic solid tumors |
|---|---|
| المؤلفون: | Postel-Vinay, S., Cosaert, J., Hattersley, M., Phillips, M., Tu, E., Durham, N., Agrawal, S., Martin, P.L., Chandrasekar, P., Ouali, K., Arnaldez, F.I. |
| المصدر: | ESMO Open ; volume 8, issue 1, page 101161 ; ISSN 2059-7029 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.esmoop.2023.101161 |
| الإتاحة: | https://doi.org/10.1016/j.esmoop.2023.101161Test https://api.elsevier.com/content/article/PII:S2059702923003812?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2059702923003812?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.63C879A2 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.esmoop.2023.101161 |
|---|